John Furey

Insider Reports History

Location
San Carlos, CA
Signature
John Furey, by /s/ Peter N. Efremenko, Attorney-In-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Furey:

Form 4 holding Director

Adaptimmune Therapeutics PLC

Security class
Option to purchase Ordinary Shares
Shares / value
660,000
Estimated value
Report date
01 Jul 2024
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
Form 4 holding Director

Vaxcyte, Inc.

Security class
Stock Option (right to buy)
Shares / value
15,372
Estimated value
Report date
12 Jun 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Vaxcyte, Inc.

Security class
No securities owned.
Shares / value
0
Estimated value
Report date
02 Jul 2024
Price
Ownership
Direct

Insider Reports Filed by John Furey

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .